Install
Trauma & PTSD
PTSD, complex trauma, EMDR, exposure therapies, and peer support.
- 3 Tracked terms
- Last 30 days Feed window
What this topic collects on
An article joins this feed when it matches these terms. Each one is also a search of its own.
Related topics
Latest in Trauma & PTSD
‘It’s a forever change’: supporting aging parents through loss of a child
58+ min ago (662+ words) (Aging Untold) — Losing a child is something no parent expects to face, no matter their age The Aging Untold experts are talking candidly about why this grief is so often overlooked in older adults and how families and caregivers can…...
New research on psychedelics could have big impact on mental health patients
1+ hour, 22+ min ago (547+ words) CHARLOTTE, N.C. (InvestigateTV) - Millions of Americans take prescription medications for mental health conditions, but those might not be enough for people with severe depression or post-traumatic stress disorder. Relief for some can be found in treatments that use drugs that produce…...
Echoes of Trauma: When children become their parents??? protectors
4+ hour, 9+ min ago (923+ words) Echoes of Trauma: When children become their parents’ protectors Some children grow up wishing their parents would protect them. Others spend their childhood trying to protect their parents from each other. Mary, not her real name, knows something about that…...
Post-Traumatic Stress Disorder (PTSD) Therapeutics Market to Reach US$4.53 Billion by 2033 at 6.9% CAGR; Rising Mental Health Awareness Drives Growth - Key Players: Pfizer, H. Lundbeck, Otsuka Pharmaceutical
3+ hour, 42+ min ago (122+ words) Press release - DataM intelligence 4 Market Research LLP - Post-Traumatic Stress Disorder (PTSD) Therapeutics Market to Reach US$4.53 Billion by 2033 at 6.9% CAGR; Rising Mental Health Awareness Drives Growth - Key Players: Pfizer, H. Lundbeck, Otsuka Pharmaceutical - published on openPR.com Post-Traumatic Stress Disorder (PTSD)…...
Inside Oregon’s Psilocybin Centers: More Than Just “Hey, Give Me Mushrooms”
3+ hour, 14+ min ago (514+ words) A new study has found that Oregon’s licensed psilocybin centers largely follow recommended safety guidelines, offering reassurance about how the first regulated psilocybin programs in the U.S. function in practice — though the cost of treatment may keep it out of…...
Gil Seton on How Trauma Can Shape Women’s Health Across a Lifetime
4+ hour, 25+ min ago (608+ words) Gil Seton Jr.’s support for organizations serving vulnerable communities provides a natural connection to a growing area of public health: understanding how trauma can influence women’s health long after a traumatic event has ended. For Gil Seton, the example…...
How the Lack of Trauma Diversity in Media Leads to the Misinterpretation of Trauma
6+ hour, 8+ min ago (213+ words) When picturing trauma representation in media, we usually envision stereotyped individuals who have experienced extreme trauma-inducing incidents, such as indoctrination, war, rape, abuse, murder and more. But what about the rest of trauma victims not represented? The people who don’t…...
Gilbert man’s book looks at emotional triggers
6+ hour, 25+ min ago (1049+ words) Gilbert businessman Lawyer Johnson’s semi-autobiographical book, “People Like Us Don’t Heal Normally,” looks at the causes of emotional triggers. When Gilbert businessman Lawyer Johnson wrote his first book, he thought he was explaining what had happened to him. Then readers…...
Understanding the impact of trauma in youth
8+ hour, 25+ min ago (647+ words) Indiana Youth Institute Senior Outreach Manager Joe Shrode, back left, introduces Hillcrest Youth Services Director of Clinical and Community Services, back right, at the Youth Worker Cafe held at the Spencer County Youth and Community Center in Chrisney held Wednesday,…...
Cognition Therapeutics Secures US Patent for Zervimesine Through 2045 Ahead of Planned Phase 3 Development
1+ day, 2+ hour ago (813+ words) Cognition Therapeutics, Inc. (NASDAQ:CGTX) has received a new composition of matter patent from the US Patent and Trademark Office (USPTO) covering a crystalline form of its investigational drug candidate zervimesine (CT1812), extending intellectual property protection for the technology until 2045. The…...